About Sam Jactel
Sam Jactel is an executive officer and director at Hypercell Technologies.
Sam Jactel first appears on SEC filings in 2021.
Experience
This experience comes from Sam Jactel's profile and from SEC filings. For roles taken from filings, the years are when the filings name Sam Jactel in the role, so the role may have started earlier or lasted longer.
CH
Columbia University Mailman School of Public Health Current
Invited Lecturer
2024 – Present
Hypercell Technologies Inc. Current
Executive officer
Member Board of Directors (2021 – Present)
2021 – Present · Ithaca, NY
On-site contamination tests for food processors.
AH
Ayble Health Current
Founder & CEO
2020 – Present
PS
Pertinent Eco-Solutions Current
Strategic Advisor
2020 – Present
GI
Ginkgo Bioworks, Inc.
Growth Strategy
2020 – 2022
FP
Flare Capital Partners
Flare Scholar
2020 – 2021
AC
Accenture
Business Strategy Consultant, Competitiveness Center of Excellence
2015 – 2019
GE
Genzyme
Global Commercial Strategy, Multiple Sclerosis Business Unit
2014
CA
Children's Healthcare of Atlanta
Sr. Pathology Researcher
2011 – 2014
Key Colleagues at Startups
The people Sam Jactel works with at each company, as listed on that company's latest Form D.
Hypercell Technologies Inc. · Form D, Oct 14, 2026
